China injects hundreds of thousands of people with the experimental Covid 19 vaccine


A Chinese pharmaceutical company has vaccinated millions of people against the experimental Covid 19 vaccine, as its Western counterparts warn against large-scale vaccine administration before rigorous scientific studies are completed.

China injects hundreds of thousands of people with the experimental Covid 19 vaccine
China National Biotech Group Co., a subsidiary of state-owned Sinopharm, has given two experimental vaccine candidates to hundreds of thousands of people under the emergency use condition approved by Beijing in July. In addition, Chinese drug company Sinovac Biotech Limited said it had vaccinated 3,000 of its employees, including the firm's chief executive, and their family members with its experimental coronavirus vaccine.

Three vaccine candidates are still undergoing Phase 3 clinical trials, including testing the safety and effectiveness of the vaccine on thousands of people. According to the World Health Organization, six other well-known candidates for Cove 19 are also in the final stages.

Regulators in individual countries usually decide whether the wider public should be allowed’ to use the vaccine only after the test has been completed. The United States, the United States, and Germany, where some of the top candidates are in the running, have not yet approved any vaccine for use outside of clinical trials.

Public health experts say frontline medical workers should be given’ priority in any emergency use of unapproved vaccines. The Chinese government approved in June an experimental vaccine for military members to be developed’ by Ken Sino Biologics Inc., then in July allowed other candidates for emergency use of the vaccine for medical workers and border inspectors.

Nine Western pharmaceutical companies promised in a joint statement this week that their experimental Covid 19 vaccines would not file for formal approval or approval until a formal medical examination was completed.

In an opinion column published Thursday, eight top US Food and Drug Administration officials said they would not allow politics to influence their assessment of the COVID19 vaccine candidates, especially after President Trump Called for the vaccine to be widely available. Presidential elections on November 3.

AstraZeneca PLC of the United States, which is preparing a key candidate, closed a series of clinical trials this week aimed at enrolling 30,000 people after a woman developed an unknown disease, according to a U.S. study. ۔ Cases may be reopened depending on the results of an independent review of potential security concerns.

In contrast, China and Russia appear keen to start using their climate vaccines, claiming to restart their economies and win global public relations.

Last month, Russia claimed to be the first country to approve the Covid 19 vaccine based on early-stage trials. Officials there say they expect large-scale vaccinations to be launched’ by the end of the year.

China, which says it has largely sealed the new coronavirus in its territory, has also taken an aggressive approach to the vaccine. Among the hundreds of thousands who have been vaccinated’ with the amount of the experimental vaccine from CNBG, a subsidiary of Sinopharm is China-based employees of Phoenix Satellite Television Holdings Limited, based in Hong Kong.

Phoenix Television said last week that it had injected its employees under China's emergency use policy, but did not say how many vaccines it had received.

Sinopharm chairman Liu Jingzhen suggested in an interview with Phoenix Television that the drug maker would offer its vaccine to more Chinese journalists, especially those working abroad. "Everybody should have hope for this kind of vaccine, since the virus has spread abroad," Mr. Liu said.

Zhou Song, a senior CNBG official, said on the company's social media account that not a single person who had not been vaccinated’ had been infected with the new coronavirus or experienced any obvious adverse reactions. Mr. Zhou also said the company was not vaccinating pregnant or breastfeeding women. The CNBG did not say whether it avoided potential dangers if it told people about it.

Mr. Zhou said the injections given so far had also shown the effectiveness of vaccines to Chinese workers working on infrastructure projects abroad.

Although Chinese infrastructure workers are not part of the company's regular clinical trials, Mr. Zhou said the company had collected data in several countries, which showed that their vaccine had kept them safe for months.

Liu Peicheng spokesman for Sinovac, which said it had injected 3,000 employees and their families, said the company's recent vaccines were purely voluntary and had been used’ before clinical trials were completed. The risks of receiving the vaccine are revealed’ to the recipients. He said the company had made the offer to its employees because it believed they had a higher risk of infection.

"We are not here to show the public the safety of the vaccine," Mr. Liu said of the emergency use.

China has promised to share any successful vaccine with other countries, many of which have strategic interests in Beijing, including the Philippines, Indonesia and Brazil. Sinovac has agreed to provide 100,000 doses of free vaccine to Bangladesh.

The United States has said that any successful vaccine will give priority to its citizens. It has already pledged to buy vaccines manufactured in the United States and Germany.

The CNBG said it had received over 500 million food orders overseas, the largest among Chinese drug makers, although it did not specify which countries had placed orders. The company is conducting Phase 3 clinical trials in the UAE and Argentina.

The company's vaccine regimen may require people to be vaccinated’ in two or three doses. CNBG said it would be able to produce 100 million doses of its Covid 19 vaccine by the end of this year, and up to one billion doses a year thereafter.


READ MORE 

An autopsy revealed that Naya Rivera had called for help as soon as she sank

Post a Comment

0 Comments